Delivery Order SPE2DB22D1202-SPE2DB24FVHR7

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication. The contract has a total ceiling value of $2,029.13 and is for a period ending on October 8, 2024. This order is not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norditropin FlexPro 10 mg/1.5 ml, a pharmaceutical product, at a ceiling value of $2,095.29. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 1.5 ml. The contract has an ultimate completion date of April 16, 2025 and a ceiling value of $2,210.95. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro, a 15 mg/1.5 mL injectable medication. The contract has a firm fixed price and a ceiling value of $4,430.69, with an ultimate completion date of October 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norditropin FlexPro 10 mg/1.5 ml medication, with a ceiling value of $1,732.80 and a performance period ending on June 12, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norditropin FlexPro 10 mg/1.5 ml, a pharmaceutical product, with a ceiling value of $2,560.91 and a period of performance through July 1, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 ml injections. The contract has a ceiling value of $2,668.51 and an ultimate completion date of July 7, 2025. The contract is not set aside and was awarded on July 3, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,191.30 firm fixed price contract is for the supply of Norditropin FlexPro 15 mg/1.5 1.5 mL, a specialty medication. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,322,240 units of Norditropin FlexPro 10 mg/1.5 1.5 ml pharmaceutical products. The contract has a firm fixed price of $3,255.52 and a completion date of April 19, 2024. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Norditropin FlexPro 10 mg/1.5 ml medication. The contract has a ceiling value of $1,396.86 and a period of performance through April 2025. It is a firm-fixed-price, non-set-aside contract for the delivery of this specific pharmaceutical product. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVHR7
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 ml medication. The contract has a ceiling value of $1,125.20 and is set to expire on July 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical and medical products, including critical care supplies and prescription drugs, to support military treatment programs and facilities, as well as other government healthcare initiatives. This particular contract does not utilize a set-aside designation.

Generated 10/22/24, 9:02 AM